Bronfman gift to Mount Sinai catalyzes genomics-based medicine

New York, NYApril 6, 2007 -- The Andrea and Charles Bronfman Philanthropies (ACBP) have given $12.5 million to establish the Charles Bronfman Institute for Personalized Medicine at The Mount Sinai Medical Center. The Leadership Gift will help propel Mount Sinai to the forefront of personalized medicine, an emerging field that uses information about a persons genetic make-up to customize strategies for the detection, treatment, and prevention of disease. At the highest level, Mr. Bronfmans grant underscores the vital role philanthropy will play in advancing next-generation medical practice.

"Personalized medicine could be the most important scientific development of the 21st century," said Charles Bronfman, Chairman of the Andrea and Charles Bronfman Philanthropies. "In an industry like medicine, where market forces are slow to change, philanthropy must play the role of catalyst facilitating growth, inspiring awareness, and serving as a basis for change. The Mount Sinai Medical Center has been a pacesetter in the area of personalized medicine and is a clear choice for receiving this grant."

Personalized medicine transforms the traditional "one-size-fits-all" model of medicine by utilizing new methods of molecular analysis to better manage a patients disease or predisposition toward a disease. It represents a dramatic departure from "evidence-based medicine," which is based on population studies and has dominated medical principles for decades. While the evidence-based approach does allow doctors to modify treatment strategies according to a particular patient's response, it relies on trial-and-error and lacks precision. Personalized medicine, on the other hand, gives doctors an answer based on an individuals unique set of genes and thereby reduces uncertainty and error in diagnosis and treatment.

"The Mount Sinai Medical Center is poised to lead the most important medical revolution taking place today, and one that will have the big

Contact: Rich Polt
The Mount Sinai Hospital / Mount Sinai School of Medicine

Page: 1 2 3

Related biology news :

1. Climate change isolates Rocky Mountain butterflies
2. Bernese Mountain Dogs prone to Borrelia burgdorferi infection
3. NIH establishes Center of Excellence for influenza research at Mount Sinai
4. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
5. Sensational find: The mini-dinosaurs from the Harz Mountains
6. Brookhaven Lab and Mount Sinai form joint Center for Translational Biomedical Imaging
7. Mount Sinai School of Medicine and Bionostra Group collaborate to develop avian flu vaccine
8. University of Kentucky author captures national attention with Lost Mountain
9. Infectious disease expert warns of spread of Rocky Mountain spotted fever
10. Mount Sinai receives NIH funding for stem cell research
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:

(Date:5/14/2019)... ... 14, 2019 , ... IMMUNE 3D®, a privately held biotechnology ... of autoimmunity, fibrosis and skin immunology. In addition, the company will leverage its ... efforts. , IMMUNE 3D®’s proprietary platform aims to study factors that affect ...
(Date:5/8/2019)... ... May 08, 2019 , ... RG+A, Inc., ... Carol S. Mann has agreed to serve as Chief Executive Officer and pharmaceutical ... Officer, effective immediately. They will join Chairman and Founder Roger Green to create ...
(Date:5/7/2019)... ... May 07, 2019 , ... ... Beach Convention and Entertainment Center from May 15- 17. At booth #226, AMGtime ... These include flexible software, biometric hardware, mobile apps, specialized industry solutions, advanced add-on ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... ... May 02, 2019 , ... Boston Robotic Hair ... area. Gone are the days of painful hair transplant procedures. Boston Robotic Hair ... is the only robotic intelligent solution to offer a minimally invasive procedure. With ...
(Date:4/25/2019)... , ... April 24, 2019 , ... ... Agents for sales and service organizations, today announced global availability of Inference ... providers and enterprises of all sizes to harness the power of Google’s ...
(Date:4/16/2019)... Md. (PRWEB) , ... April 16, 2019 , ... ... honor Blue Sources and their project partner, the U.S. Army Center for Environmental ... of Aquatic Biomonitor Through Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company located ...
(Date:4/15/2019)... ... 2019 , ... Sirrus, Inc., a developer of novel electron-deficient ... to increase production of methylene malonate monomers and oligomers. , The expanded bench ... production facility, which is scheduled to break ground in 2019. “The expanded facility ...
Breaking Biology Technology:
Cached News: